C. Satish Chandran
Direktor/Vorstandsmitglied bei STATERA BIOPHARMA, INC.
Profil
C.
Satish Chandran is the founder of Nucleonics, Inc. (founded in 2001) and Somahlution LLC (founded in 2010).
At Somahlution LLC, he holds the title of Chief Executive Officer & Director.
Dr. Chandran's current job(s) include being the Chief Executive Officer at Akshaya Bio, Inc. (since 2021), President & Chief Executive Officer at Lays Sciences, and Director at Statera Biopharma, Inc. In the past, Dr. Chandran worked as an Associate Professor at Thomas Jefferson University, a Professor at North Dakota State University (from 2010 to 2012), and as the President, Chief Operating & Technology Officer at Marizyme, Inc. (from 2020 to 2021).
Dr. Chandran obtained a doctorate degree from Memorial University of Newfoundland.
Aktive Positionen von C. Satish Chandran
Unternehmen | Position | Beginn |
---|---|---|
STATERA BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 24.02.2022 |
Akshaya Bio, Inc.
Akshaya Bio, Inc. Pharmaceuticals: MajorHealth Technology Akshaya Bio, Inc. develops therapeutics for infectious diseases and cancer. Its technology Chimigen platform to develop therapeutic vaccines for patients with chronic viral infections as well as prophylactic vaccines to prevent infections. The company was founded by Rajan George and is headquartered in Edmonton, Canada. | Vorstandsvorsitzender | 01.04.2021 |
Somahlution LLC
Somahlution LLC Medical DistributorsDistribution Services Somahlution LLC provides medical products focused on ischemia reperfusion injury using patented and proprietary technologies. It offers DuraGraft, one time intraoperative vascular graft treatment that maintains endothelial function and structure. The company was founded by Vithalbhai Dhaduk and C. Satish Chandran in 2010 and is headquartered in Jupiter, FL. | Gründer | 01.01.2010 |
Lays Sciences | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von C. Satish Chandran
Unternehmen | Position | Ende |
---|---|---|
MARIZYME, INC. | Präsident | 02.04.2021 |
North Dakota State University | Corporate Officer/Principal | 01.01.2012 |
Thomas Jefferson University | Corporate Officer/Principal | - |
Nucleonics, Inc.
Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA. | Gründer | - |
Ausbildung von C. Satish Chandran
Memorial University of Newfoundland | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MARIZYME, INC. | Health Technology |
STATERA BIOPHARMA, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Nucleonics, Inc.
Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA. | Health Technology |
Akshaya Bio, Inc.
Akshaya Bio, Inc. Pharmaceuticals: MajorHealth Technology Akshaya Bio, Inc. develops therapeutics for infectious diseases and cancer. Its technology Chimigen platform to develop therapeutic vaccines for patients with chronic viral infections as well as prophylactic vaccines to prevent infections. The company was founded by Rajan George and is headquartered in Edmonton, Canada. | Health Technology |
Somahlution LLC
Somahlution LLC Medical DistributorsDistribution Services Somahlution LLC provides medical products focused on ischemia reperfusion injury using patented and proprietary technologies. It offers DuraGraft, one time intraoperative vascular graft treatment that maintains endothelial function and structure. The company was founded by Vithalbhai Dhaduk and C. Satish Chandran in 2010 and is headquartered in Jupiter, FL. | Distribution Services |
Lays Sciences |